Literature DB >> 1717981

Characterization of a neu/c-erbB-2 protein-specific activating factor.

K Dobashi1, J G Davis, Y Mikami, J K Freeman, J Hamuro, M I Greene.   

Abstract

The neu oncogene encodes a tyrosine kinase with growth factor receptor-like properties. A neu protein-specific activating factor (NAF) was partially purified from medium conditioned by the transformed human T-cell line ATL-2. NAF was able to stimulate the tyrosine-specific kinase activity of the neu protein (p185neu), induce dimerization and internalization, and increase the growth of cells bearing the neu protein. The effects of NAF were mediated by an interaction with the p185neu extracellular domain. NAF had no effect on the epidermal growth factor receptor kinase activity and no effect on cells that express that receptor. Further analysis of NAF and of other recently described neu protein-activating activities should help clarify the role of the neu protein in cell growth and transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717981      PMCID: PMC52553          DOI: 10.1073/pnas.88.19.8582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

4.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

5.  Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo.

Authors:  J A Drebin; V C Link; M I Greene
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

6.  TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.

Authors:  M Okada; M Maeda; Y Tagaya; Y Taniguchi; K Teshigawara; T Yoshiki; T Diamantstein; K A Smith; T Uchiyama; T Honjo
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

7.  The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.

Authors:  A L Schechter; M C Hung; L Vaidyanathan; R A Weinberg; T L Yang-Feng; U Francke; A Ullrich; L Coussens
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

8.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

9.  Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.

Authors:  K Teshigawara; M Maeda; K Nishino; T Nikaido; T Uchiyama; M Tsudo; Y Wano; J Yodoi
Journal:  J Mol Cell Immunol       Date:  1985

10.  Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement.

Authors:  M Maeda; A Shimizu; K Ikuta; H Okamoto; M Kashihara; T Uchiyama; T Honjo; J Yodoi
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  17 in total

1.  Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.

Authors:  Y Mikami; J G Davis; K Dobashi; W C Dougall; J N Myers; V I Brown; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

3.  A kinase associated with chromatin that can be activated by ligand-p185c-Neu or epidermal growth factor-receptor interactions.

Authors:  A Samanta; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

4.  Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.

Authors:  N Kiyokawa; D H Yan; M E Brown; M C Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

Review 5.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha.

Authors:  H Kalthoff; C Roeder; J Gieseking; I Humburg; W Schmiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

Authors:  G D Plowman; J M Culouscou; G S Whitney; J M Green; G W Carlton; L Foy; M G Neubauer; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.

Authors:  X L Quian; S J Decker; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 10.  Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Authors:  N Normanno; F Ciardiello; R Brandt; D S Salomon
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.